Latest News

Add to Favorites Subscribe Share
newswise-fb-share-

Showing results

5160 of 217991
Embargo will expire:
21-Aug-2019 11:00 AM EDT
Released to reporters:
19-Aug-2019 3:05 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 21-Aug-2019 11:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Social and Behavioral Sciences

Newswise: EMBO Laboratory Leadership Training Offered at the Stowers Institute

Article ID: 717643

EMBO Laboratory Leadership Training Offered at the Stowers Institute

Stowers Institute for Medical Research

This October, the Stowers Institute for Medical Research will host a session of the EMBO Laboratory Leadership for Group Leaders Course at its campus in Kansas City, Missouri.

Released:
19-Aug-2019 2:05 PM EDT
Open in New Tab
Comment

Languages:

English

Newswise: Zimmerli Art Museum Presents Dimensionism: Modern Art in the Age of Einstein

Article ID: 717667

Zimmerli Art Museum Presents Dimensionism: Modern Art in the Age of Einstein

Rutgers University-New Brunswick

Dimensionism: Modern Art in the Age of Einstein comes to Rutgers–New Brunswick’s Zimmerli Art Museum on Sept. 3 and will examine works by celebrated artists, including Marcel Duchamp, Isamu Noguchi, Dorothea Tanning and includes the return of Helen Lundeberg’s Self Portrait (1944) which belongs to the Zimmerli Art Museum and has been a prominent part of the traveling exhibit. In conjunction with the exhibit’s infusion of art and science, Rutgers physicists, engineers and astronomers will also incorporate the exhibit into upcoming curriculum, programs and a symposium.

Released:
19-Aug-2019 2:05 PM EDT
Open in New Tab
Comment

Arts and Humanities

Embargo will expire:
22-Aug-2019 12:00 AM EDT
Released to reporters:
19-Aug-2019 2:00 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 22-Aug-2019 12:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

logoMOFFITT_2c_RGB.jpg

Article ID: 717657

Moffitt Researchers Discover Possible New Treatment Strategy for Lung Cancer

Moffitt Cancer Center

Lung cancer is the second most common cancer found in both men and women. It is estimated there will be roughly 228,000 new lung cancer cases this year, and nearly 30% of those patients will have mutations in the KRAS pathway. This type of mutation makes the cancer more aggressive and difficult to treat. Researchers at Moffitt Cancer Center are hoping to change that. In a new study published in Cancer Research, the team discovered a new treatment approach that may help this group of patients.

Released:
19-Aug-2019 2:00 PM EDT
Open in New Tab
Comment
Horizontal-CHLA-Logo.png

Article ID: 717653

Do You Know How Heavy Your Child's Backpack Is?

Children's Hospital Los Angeles

Backpacks that are too heavy can cause pain, lead to serious injury and affect posture. Children can end up with injuries in their joints, back/spine, muscles, neck and shoulders from backpacks that are too heavy.

Released:
19-Aug-2019 1:35 PM EDT
EXPERT AVAILABLE
Open in New Tab
Comment
Embargo will expire:
21-Aug-2019 1:00 PM EDT
Released to reporters:
19-Aug-2019 1:30 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 21-Aug-2019 1:00 PM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Article ID: 717656

Baylor Scott & White Health’s 15 Years of Research Brings More Access to Innovative Heart Care

Baylor Scott and White Health

On Aug. 16, the U.S. Food and Drug Administration (FDA) approved a minimally invasive open-heart surgery alternative for low surgical-risk patients following the successful outcome of the PARTNER 3 and Evolut LR clinical trials. Baylor Scott & White The Heart Hospital – Plano and Baylor Scott & White Medical Center – Temple participated in the PARTNER 3 trial and Baylor Scott & White Heart and Vascular Hospital – Dallas participated in the Evolut LR trial, following FDA approval of transcatheter aortic valve replacement (TAVR) for inoperable patients in 2012, high-risk patients in 2014 and medium-risk patients in 2017.

Released:
19-Aug-2019 1:30 PM EDT
Open in New Tab
Comment

Showing results

5160 of 217991

Chat now!